Donald Trump’s return to the presidency in 2025 brought with it a resurgence of the “America First” doctrine, a policy ...

A doctor is facing an abuse and neglect charge after a schizophrenic man with serious injuries was able to leave a Colonial Heights rehabilitation and nursing center, against medical advice, with ...

Adma Biologics (ADMA) concluded the recent trading session at $16.47, signifying a +1.92% move from its prior day's close.

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce the launch of the NULISAseq™ Inflammation Panel AQ, setting a new standard ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced positive results for its Phase 2 clinical trial evaluating the safety and immunogenicity of ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

The push to regard addiction as a disease is well-intentioned—driven by a desire to lessen stigma—but fails to account for the many facets and facts of the condition. Worse, it robs sufferers ...